Scaffold Redesign

Scaffold Redesign is a methodological contribution in medicinal chemistry that involves the systematic modification of a molecular scaffold to generate novel chemotypes while retaining desired biological activity, distinguishing it from other scaffold hopping approaches by prioritizing structural innovation and patentability.

109

Publications

3.6K

Citations

802

Authors

218

Institutions

Publications per year

2017–2026

35

Authors

802

  1. AN
    Adam Nelson

    University of Leeds, United Kingdom

    3 publications · 148 citations

    3

    h-index

  2. SP
    Stephen P. Marsden

    University of Leeds, United Kingdom

    3 publications · 148 citations

    3

    h-index

  3. PG
    Philip G. E. Craven

    University of Leeds, United Kingdom

    3 publications · 148 citations

    3

    h-index

  4. RP
    Rune Pagh Nielsen

    Aarhus University, Denmark

    2 publications · 57 citations

    2

    h-index

  5. NI
    Naoki Ishida

    Kyoto University, Japan

    2 publications · 49 citations

    2

    h-index

1–5 of 802

Venues

  1. European Journal of Medicinal Chemistry

    11 publications · 259 citations

    11

    h-index

  2. Bioorganic & Medicinal Chemistry Letters

    11 publications · 198 citations

    11

    h-index

  3. Bioorganic & Medicinal Chemistry

    11 publications · 276 citations

    10

    h-index

  4. Tetrahedron

    7 publications · 545 citations

    7

    h-index

  5. Journal of Medicinal Chemistry

    6 publications · 465 citations

    6

    h-index

1–5